<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04879706</url>
  </required_header>
  <id_info>
    <org_study_id>AZ 37/21</org_study_id>
    <nct_id>NCT04879706</nct_id>
  </id_info>
  <brief_title>Proenkephalin A and Kidney Replacement Therapy</brief_title>
  <official_title>Proenkephalin A at Initiation and Discontinuation of Kidney Replacement Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Giessen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Giessen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute kidney injury (AKI) is a common problem encountered in the intensive care unit (ICU),&#xD;
      estimated to occur in up to 60% of all critically ill patients, depending on the definition.&#xD;
      Recent large randomized clinical trials in critical care nephrology have focused on the&#xD;
      optimal timing of initiation of acute kidney replacement therapy (KRT). However, less is&#xD;
      known about the ideal circumstances in which KRT may be successfully discontinued.&#xD;
&#xD;
      The novel serum-biomarker proenkephalin A 119-159 (penkid) has been found to be strongly&#xD;
      negatively correlated with measured GFR. Whether penkid may have a role in initiation and&#xD;
      discontinuation of KRT remains unknown.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute kidney injury (AKI) is a common problem encountered in the intensive care unit (ICU),&#xD;
      estimated to occur in up to 60% of all critically ill patients, depending on the definition.&#xD;
      Recent large randomized clinical trials in critical care nephrology have focused on the&#xD;
      optimal timing of initiation of acute kidney replacement therapy (KRT). However, less is&#xD;
      known about the ideal circumstances in which KRT may be successfully discontinued. KRT is a&#xD;
      complex and expensive therapy, with complications including catheter-associated infections,&#xD;
      hemorrhage, hemodynamic instability, and potential delayed renal recovery.&#xD;
&#xD;
      The novel serum-biomarker proenkephalin A 119-159 (penkid) is a stable fragment derived from&#xD;
      the precursor enkephalins, which are known as small endogenous opioid peptides and are&#xD;
      produced throughout the human body, including the kidneys. Plasma concentrations of penkid&#xD;
      have been found to be strongly negatively correlated with measured glomerular filtration&#xD;
      rate. Whether penkid may have a role in initiation and discontinuation of KRT remains&#xD;
      unknown.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 9, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Penkid levels at KRT initiation</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>Serial assessment of penkid in patients undergoing KRT</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Penkid levels at discontinuation of KRT</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>Serial assessment of penkid in patients undergoing KRT</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>AKI necessitating KRT</arm_group_label>
    <description>Patients with AKI necessitating KRT</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>None planned</intervention_name>
    <description>No intervention planned</description>
    <arm_group_label>AKI necessitating KRT</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with severe AKI necessitating KRT at the University Hospital Giessen,&#xD;
        Giessen, Germany&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients ≥18 years of age with AKI requiring KRT&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic kidney disease with estimated glomerular filtration rate &lt;30 mL/min/1.73 m2&#xD;
&#xD;
          -  Non-end stage renal disease with extracorporeal ultrafiltration due to diuretic-&#xD;
             resistant fluid overload&#xD;
&#xD;
          -  Decision to limit therapeutic interventions&#xD;
&#xD;
          -  History of solid-organ transplants&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Werner Seeger, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Giessen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Faeq Husain-syed, MD</last_name>
    <phone>+4964198542378</phone>
    <email>faeq.husain-syed@innere.med.uni-giessen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Horst-Walter Birk, MD</last_name>
    <phone>+4964198542378</phone>
    <email>horst-walter.birk@innere.med.uni-giessen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Gießen and Marburg</name>
      <address>
        <city>Gießen</city>
        <state>Hessen</state>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faeq Husain-Syed, MD</last_name>
      <phone>+49 641 985 42378</phone>
      <email>faeq.husain-syed@innere.med.uni-giessen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Kim H, Hur M, Struck J, Bergmann A, Di Somma S. Proenkephalin Predicts Organ Failure, Renal Replacement Therapy, and Mortality in Patients With Sepsis. Ann Lab Med. 2020 Nov;40(6):466-473. doi: 10.3343/alm.2020.40.6.466. Epub 2020 Jun 17.</citation>
    <PMID>32539302</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>May 3, 2021</study_first_submitted>
  <study_first_submitted_qc>May 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 10, 2021</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

